What is Sarepta Therapeutics, Inc.'s gain (loss) on investments?

Sarepta Therapeutics, Inc. (SRPT) reported gain (loss) on investments of -$1.71M in Q1 2026.

How has Sarepta Therapeutics, Inc.'s gain (loss) on investments changed year-over-year?

Sarepta Therapeutics, Inc.'s gain (loss) on investments increased by 98.1% year-over-year, from -$90.73M to -$1.71M.

Sarepta Therapeutics, Inc. SRPT Gain (Loss) on Investments

Gain (Loss) on Investments at other companies

Arthur J. GallagherAJG

-$2M-133%

Cavco IndustriesCVCO

$1.05M—

Dominion EnergyD

-$162M-39.7%

Cadence Design SystemsCDNS

$13.93M+877%

PayPal Holdings, Inc.PYPL

-$101M-310%

MarshMRSH

$6M+20.0%

Segments

By segment

See full

All Other Segments$1.71M-98.1%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.76B-63.1%

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnInvestments.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s gain (loss) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s gain (loss) on investments?: Sarepta Therapeutics, Inc. (SRPT) reported gain (loss) on investments of -$1.71M in Q1 2026.
How has Sarepta Therapeutics, Inc.'s gain (loss) on investments changed year-over-year?: Sarepta Therapeutics, Inc.'s gain (loss) on investments increased by 98.1% year-over-year, from -$90.73M to -$1.71M.